MedTrace Logo

Evaluate The Improvement In Symptoms Of Patients Using Cationorm After Pterygium Surgery

NCT07064187 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-08-06

No results posted yet for this study

Summary

The goal of this interventional clinical trial is to learn whether Cationorm can improve symptoms after pterygium surgery. The main question it aims to answer is what is the level of improvement of symptoms after pterygium surgery.

Researchers will compare with other artificial tears (hyaluronic acid, polymers or cellulose derivatives eye drops) arm to see if Cationorm is similar or superior in terms of improvement of symptoms after pterygium surgery.

Participants will

* Take 1 drop Cationorm/artificial tear before and after surgery and during follow up.
* Visit for checkups after 7 days

Conditions

  • Ocular Discomfort

Interventions

DRUG

Cationorm single-dose eye drop

Cationorm single-dose eye drop is a preservative-free, cationic oil-in-water nano-emulsion.

DRUG

Artificial tear eye drop

Artificial tear eye drops are hyaluronic acid, polymers or cellulose derivatives eye drops

Sponsors & Collaborators

  • Nguyen Viet Giap

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-15
Primary Completion
2022-08-15
Completion
2022-08-15

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07064187 on ClinicalTrials.gov